Challenges in the Assessment of Nanotoxicity, Recommendations, and Safe-by-Design Nanomedicines to Counter Toxicological Problems

2021 ◽  
pp. 393-444
Author(s):  
G. V. S. Subbaroy Sarma ◽  
Manoj Kumar Enamala ◽  
Maria P. Nikolova ◽  
Murthy Chavali ◽  
Sudhakar Reddy Pamanji
Keyword(s):  
Nano Today ◽  
2021 ◽  
Vol 37 ◽  
pp. 101065
Author(s):  
Jerome Rose ◽  
Melanie Auffan ◽  
Camille de Garidel-Thoron ◽  
Sebastien Artous ◽  
Claire Auplat ◽  
...  

2021 ◽  
Vol 43 (1) ◽  
pp. 4-7
Author(s):  
Linda J. Johnston ◽  
Norma Gonzalez-Rojano ◽  
Kevin J. Wilkinson ◽  
Baoshan Xing

Abstract Nanotechnology has developed rapidly in the last two decades with significant effort focused on the development of nano-enabled materials with new or improved properties that offer solutions for current world challenges. The commercialization of products containing engineered nanomaterials (ENM) has progressed much more rapidly than the development of practical approaches to ensure their safe and sustainable use. The lack of adequate detection and characterization techniques and reproducible and validated methods for toxicological studies have been identified as major limitations. The rapid development of ENM of increasing complexity and diversity and concerns over the adequacy of existing regulations also contribute to safety concerns with these materials. The full potential of nanotechnology can only be realized when feasible, cost-effective strategies to ensure a safe-by-design approach, effective risk assessment approaches and appropriate regulatory guidelines are in place.


Nanomaterials ◽  
2021 ◽  
Vol 11 (4) ◽  
pp. 1004
Author(s):  
Pamela Floris ◽  
Stefania Garbujo ◽  
Gabriele Rolla ◽  
Marco Giustra ◽  
Lucia Salvioni ◽  
...  

In the biomedical field, gold nanoparticles (GNPs) have attracted the attention of the scientific community thanks to their high potential in both diagnostic and therapeutic applications. The extensive use of GNPs led researchers to investigate their toxicity, identifying stability, size, shape, and surface charge as key properties determining their impact on biological systems, with possible strategies defined to reduce it according to a Safe-by-Design (SbD) approach. The purpose of the present work was to analyze the toxicity of GNPs of various sizes and with different coating polymers on the developing vertebrate model, zebrafish. In particular, increasing concentrations (from 0.001 to 1 nM) of 6 or 15 nm poly-(isobutylene-alt-maleic anhydride)-graft-dodecyl polymer (PMA)- or polyethylene glycol (PEG)-coated GNPs were tested on zebrafish embryos using the fish embryo test (FET). While GNP@PMA did not exert significant toxicity on zebrafish embryos, GNP@PEG induced a significant inhibition of embryo viability, a delay of hatching (with the smaller size NPs), and a higher incidence of malformations, in terms of tail morphology and eye development. Transmission electron microscope analysis evidenced that the more negatively charged GNP@PMA was sequestered by the positive charges of chorion proteins, with a consequent reduction in the amount of NPs able to reach the developing embryo and exert toxicological activity. The mild toxic response observed on embryos directly exposed to GNP@PMA suggest that these NPs are promising in terms of SbD development of gold-based biomedical nanodevices. On the other hand, the almost neutral GNP@PEG, which did not interact with the chorion surface and was free to cross chorion pores, significantly impacted the developing zebrafish. The present study raises concerns about the safety of PEGylated gold nanoparticles and contributes to the debated issue of the free use of this nanotool in medicine and nano-biotechnologies.


NanoImpact ◽  
2021 ◽  
pp. 100335
Author(s):  
Beatrice Salieri ◽  
Leire Barruetabeña ◽  
Isabel Rodríguez-Llopis ◽  
Nicklas Raun Jacobsen ◽  
Nicolas Manier ◽  
...  

NanoImpact ◽  
2021 ◽  
pp. 100354
Author(s):  
Isabella Tavernaro ◽  
Susan Dekkers ◽  
Lya G. Soeteman-Hernández ◽  
Petra Herbeck-Engel ◽  
Cornelle Noorlander ◽  
...  

ACS Nano ◽  
2017 ◽  
Vol 11 (1) ◽  
pp. 501-515 ◽  
Author(s):  
Hendrik Naatz ◽  
Sijie Lin ◽  
Ruibin Li ◽  
Wen Jiang ◽  
Zhaoxia Ji ◽  
...  

2020 ◽  
Vol 33 (4) ◽  
pp. 915-932 ◽  
Author(s):  
Mariana Colaço ◽  
Ana P. Marques ◽  
Sandra Jesus ◽  
Alana Duarte ◽  
Olga Borges
Keyword(s):  

2018 ◽  
Vol 6 (12) ◽  
pp. 3356-3372 ◽  
Author(s):  
Thanusu Parandhaman ◽  
Sujoy K. Das

Safe-by-design synthesis of a poly-cationic functionalized graphene–silver nanocomposite as a novel eco-benign antibacterial, biofilm inhibiting and disrupting agent.


2020 ◽  
Vol 7 (12) ◽  
pp. 1903200 ◽  
Author(s):  
Artur Filipe Rodrigues ◽  
Leon Newman ◽  
Dhifaf Jasim ◽  
Sourav P. Mukherjee ◽  
Jun Wang ◽  
...  

Micromachines ◽  
2019 ◽  
Vol 10 (12) ◽  
pp. 825
Author(s):  
Panagiotis Karayannis ◽  
Fotini Petrakli ◽  
Anastasia Gkika ◽  
Elias P. Koumoulos

The aim of this study is to provide a detailed strategy for Safe-by-Design (SbD) 3D-printed lab-on-a-chip (LOC) device manufacturing, using Fused Filament Fabrication (FFF) technology. First, the applicability of FFF in lab-on-a-chip device development is briefly discussed. Subsequently, a methodology to categorize, identify and implement SbD measures for FFF is suggested. Furthermore, the most crucial health risks involved in FFF processes are examined, placing the focus on the examination of ultrafine particle (UFP) and Volatile Organic Compound (VOC) emission hazards. Thus, a SbD scheme for lab-on-a-chip manufacturing is provided, while also taking into account process optimization for obtaining satisfactory printed LOC quality. This work can serve as a guideline for the effective application of FFF technology for lab-on-a-chip manufacturing through the safest applicable way, towards a continuous effort to support sustainable development of lab-on-a-chip devices through cost-effective means.


Sign in / Sign up

Export Citation Format

Share Document